Protocol
GLOW (70 mg Vial)
Complete dosage protocol and reconstitution guide for GLOW (70 mg Vial).
Calculator preset
Run the vial math before tracking.
At ~23.3 mg/mL, 1 unit ~ 233 mcg total; the daily 2,330 mcg dose is 10 units (0.10 mL) on a U-100 syringe.
01 · At a glance
Quickstart Highlights
GLOW is a research peptide blend combining GHK-Cu , TB-500 (Thymosin Beta-4 fragment), and BPC-157 in one 70 mg vial. Each component has been studied for its regenerative and healing properties across various tissues [1] [5] . By delivering all three in one formulation, GLOW aims to synergistically promote tissue repair, inflammation reduction, and wound healing beyond what each peptide might achieve alone.
02 · Dosing & reconstitution
Dosing & Reconstitution Guide
A practical calculator-ready setup based on the imported protocol reference. Use these values as a math starting point, then verify every entry against your own vial, diluent, and professional guidance.
Standard Approach (3 mL = 23.3 mg/mL)
2,330 mcg (2.33 mg) once daily for 4 weeks.
Reconstitution Steps
- Draw 3.0 mL bacteriostatic water with a sterile syringe.
- Inject slowly down the vial wall to minimize foaming.
- Gently swirl or roll the vial until fully dissolved (do not shake vigorously).
- Label with reconstitution date and refrigerate at 2–8 °C (35.6–46.4 °F) , protected from light.
- Use within 4 weeks for optimal potency and safety.
03 · What you'll need
Supplies Needed
Keep this as a planning checklist. TNHL does not sell or verify supplies on this page, and no supplier quality claims are made here.
- 4 weeks (1 vial): 3 mL → 1 × 10 mL bottle
- 4 weeks: 56 swabs (2 per day) → recommend 1 × 100-count box
Protocol Overview
- Goal: Support comprehensive tissue healing through synergistic peptide mechanisms—collagen synthesis (GHK-Cu), cell migration and angiogenesis (TB-500), and localized repair with anti-inflammatory effects (BPC-157) [1] [4] [5] .
- Schedule: Daily subcutaneous injections for 4 weeks at a consistent dose, followed by a 2–4 week rest period to assess progress before considering another cycle. Dose: 2,330 mcg (2.33 mg) total blend daily, providing approximately 1.7 mg GHK-Cu, 0.33 mg TB-500, and 0.33 mg BPC-157 per injection.
- Reconstitution: 3.0 mL per 70 mg vial (23.3 mg/mL) for precise unit measurements.
- Storage: Lyophilized vials frozen; reconstituted solutions refrigerated; use within 4 weeks.
Dosing Protocol
- Straightforward daily dosing approach for balanced peptide delivery.
- Daily Dose: 2,330 mcg (10 units / 0.10 mL) maintained throughout the 4-week cycle.
- Frequency: Once per day (subcutaneous), at a consistent time preferred.
- Cycle Length: 4 weeks of daily dosing, followed by 2–4 weeks off to evaluate progress and allow receptor resetting.
- Volume: Per-injection volume (~0.1 mL) is well below the 1.0–1.5 mL comfort threshold for subcutaneous administration [9] .
- Syringe Recommendation: Use 0.3 mL (30-unit) insulin syringes for greater measurement precision at low volumes.
Storage Instructions
- Proper storage preserves peptide stability and potency.
- Lyophilized: Store at −20 °C (−4 °F) or below for long-term stability (months to over a year) [8] .
- If freezer unavailable, refrigeration at 2–8 °C (35.6–46.4 °F) is acceptable for shorter durations (weeks).
- Store in sealed container with desiccant if possible to prevent moisture absorption.
- Reconstituted: Refrigerate at 2–8 °C (35.6–46.4 °F) at all times when not in use [8] .
- Do not freeze reconstituted solution.
04 · Good to know
Important Notes
- This GLOW page is for educational research organization only.
- Confirm route, dose, contraindications, monitoring, storage, and cycle decisions with qualified professional guidance.
- Use sterile technique, rotate sites when applicable, and log missed doses, reactions, and inventory changes.
05 · How it works
How This Works
GLOW is a research peptide blend combining GHK-Cu , TB-500 (Thymosin Beta-4 fragment), and BPC-157 in one 70 mg vial.
Each component has been studied for its regenerative and healing properties across various tissues [1] [5] .
By delivering all three in one formulation, GLOW aims to synergistically promote tissue repair, inflammation reduction, and wound healing beyond what each peptide might achieve alone.
The library page pairs that educational context with calculator-ready vial math, so users can understand the protocol structure and then track their own entered values in one place.
06 · Daily habits
Lifestyle Factors
- Keep meals, training, sleep, and recovery notes in the journal so trends are easier to review.
- Track body metrics only if they are relevant to the user's goal and approved data sources.
- Use consistent timing and logging habits so adherence data is meaningful.
07 · What to expect
Potential Benefits & Side Effects
- GLOW observations should be recorded conservatively: expected research endpoints, tolerability notes, injection-site reactions when applicable, sleep, appetite, energy, mood, and any adverse or unusual response.
- This section is not a claim of therapeutic benefit.
08 · Technique
Injection Technique
- Wash hands with soap and water.
- Wipe the vial stopper and chosen site with alcohol, then let both dry.
- Confirm the vial concentration, calculator result, and intended draw amount before loading the syringe.
- Use the route and needle technique directed by a qualified professional or product instructions.
- For subcutaneous injections, rotate sites and inject slowly to limit leakage and irritation.
- Do not reuse needles or syringes.
- Dispose of sharps in a puncture-resistant container.
- Return stored items promptly to the correct temperature.
- Log dose, site, date, time, inventory change, and any observation.
09 · Evidence
References
Related pages